CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 1055 | 1204 | 87.6% | |
| CKD 4 | 2008 | 1630 | 1879 | 86.7% | |
| CKD 5 | 2009 | 371 | 418 | 88.8% | |
| CKD 5 | 2010 | 320 | 347 | 92.2% | |
| CKD 5 | 2011 | 326 | 370 | 88.1% | |
| CKD 5 | 2012 | 319 | 361 | 88.4% | |
| CKD 5 | 2013 | 317 | 358 | 88.5% | |
| CKD003 | 2014 | 295 | 322 | 91.6% | |
| CKD003 | 2015 | 297 | 333 | 89.2% | |
| CKD003 | 2016 | 283 | 308 | 91.9% |
